Bio-Rad Laboratories (BIO) Gross Margin Growth (3y) (2012 - 2026)

Bio-Rad Laboratories (BIO) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 63.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 17.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 21.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 15.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -324.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 56.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 311.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -164.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Bio-Rad Laboratories 8.53 Bn 6.97 Bn 309.40 Mn -129.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -129.00
Dec 31, 2025 -458.00
Sep 30, 2025 -214.00
Jun 30, 2025 -416.00
Mar 31, 2025 -523.00
Dec 31, 2024 -334.00
Sep 30, 2024 -365.00
Jun 30, 2024 -41.00
Mar 31, 2024 -175.00
Dec 31, 2023 -448.00
Sep 30, 2023 -363.00
Jun 30, 2023 -135.00
Mar 31, 2023 -198.00
Dec 31, 2022 147.00
Sep 30, 2022 -3.00
Jun 30, 2022 340.00
Mar 31, 2022 122.00
Dec 31, 2021 66.00
Sep 30, 2021 584.00
Jun 30, 2021 364.00